TABLE 2.
Mutanta | Location in SU | Processingb | Incorporationc | Infectivityd |
---|---|---|---|---|
G47 | N terminus | + | + | − |
G57 | VRA | + | + | − |
G77 | VRA | + | + | − |
G107 | VRA | + | + | − |
G126 | Between VRA and VRB | + | + | − |
G149 | Between VRA and VRB | + | + | − |
G167 | VRB | + | + | − |
G190 | Between VRB and PRR | + | + | − |
G219 | PRR | + | + | + |
G223 | PRR | − | − | − |
G250 | PRR | + | + | − |
G315 | C terminus | + | + | − |
G339 | C terminus | − | − | − |
G379 | C terminus | + | + | − |
G439 | C terminus | + | + | − |
Linkers were inserted after the residue indicated (e.g., between amino acids 47 and 48 in the first insertion mutant).
SU protein was detected (+) or not (−) in lysates from transiently transfected 293T cells, as described in Materials and Methods.
SU protein was present (+) or absent (−) in retroviral vector particles produced in 293T cells at 35°C.
Vector particles bearing mutant envelopes did (+) or did not (−) infect MDTF-Pit1 target cells.